Xponance’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Sell |
18,069
-7,878
| -30% | -$143K | ﹤0.01% | 1098 |
|
|
2025
Q1 | $515K | Sell |
25,947
-2,965
| -10% | -$58.8K | 0.01% | 922 |
|
|
2024
Q4 | $496K | Sell |
28,912
-409
| -1% | -$7.01K | ﹤0.01% | 951 |
|
|
2024
Q3 | $586K | Buy |
29,321
+10,853
| +59% | +$217K | 0.01% | 887 |
|
|
2024
Q2 | $206K | Buy |
18,468
+5,597
| +43% | +$62.6K | ﹤0.01% | 1173 |
|
|
2024
Q1 | $84.9K | Sell |
12,871
-132
| -1% | -$871 | ﹤0.01% | 1249 |
|
|
2023
Q4 | $58.8K | Sell |
13,003
-379
| -3% | -$1.71K | ﹤0.01% | 1232 |
|
|
2023
Q3 | $47.9K | Buy |
13,382
+226
| +2% | +$809 | ﹤0.01% | 1206 |
|
|
2023
Q2 | $48.5K | Buy |
13,156
+1,271
| +11% | +$4.69K | ﹤0.01% | 1226 |
|
|
2023
Q1 | $39.3K | Buy |
11,885
+1,296
| +12% | +$4.29K | ﹤0.01% | 1199 |
|
|
2022
Q4 | $41.1K | Buy |
10,589
+208
| +2% | +$807 | ﹤0.01% | 1191 |
|
|
2022
Q3 | $25K | Buy |
10,381
+299
| +3% | +$720 | ﹤0.01% | 1175 |
|
|
2022
Q2 | $20K | Buy |
+10,082
| New | +$20K | ﹤0.01% | 1181 |
|